[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioventus Inc Cl A 4721 EMPEROR BOULEVARD SUITE 100 DURHAM NC 27703 USA

www.bioventus.com Employees: 930 P: 919-474-6700

Sector:

Medical

Description:

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 958,982
Enterprise Value, $K 1,201,692
Shares Outstanding, K 83,535
Float, K 55,551
% Float 66.50%
Short Interest, K 2,184
Short Float 2.61%
Days to Cover 3.25
Short Volume Ratio 0.75
% of Insider Shareholders 33.50%
% of Institutional Shareholders 62.94%

Financials:

Annual Sales, $ 568,090 K
Annual Net Income, $ 22,730 K
Last Quarter Sales, $ 132,090 K
Last Quarter Net Income, $ 3,110 K
EBIT, $ 65,000 K
EBITDA, $ 112,010 K

Growth:

1-Year Return 77.43%
3-Year Return 234.69%
5-Year Return -26.36%
5-Year Revenue Growth 76.89%
5-Year Earnings Growth -91.01%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.15 on 05/06/26
Next Earnings Date 08/05/26 [--]
Earnings Per Share ttm 0.75
EPS Growth vs. Prev Qtr -37.50%
EPS Growth vs. Prev Year 87.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BVS Ratios

Ratio
Price/Earnings ttm 15.51
Price/Earnings forward 15.13
Price/Earnings to Growth 1.51
Return-on-Equity % 29.97%
Return-on-Assets % 9.52%
Profit Margin % 4.00%
Debt/Equity 1.16
Price/Sales 1.71
Price/Cash Flow 9.32
Price/Book 4.24
Book Value/Share 2.80
Interest Coverage -1.97
60-Month Beta 0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.